about
Combined Use of Oligopeptides, Fragment Libraries, and Natural Compounds: A Comprehensive Approach To Sample the Druggability of Vascular Endothelial Growth Factor.Unveiling prolyl oligopeptidase ligand migration by comprehensive computational techniques.Combating virulence of Gram-negative bacilli by OmpA inhibition.Inhibition of Human Enhancer of Zeste Homolog 2 with Tambjamine Analogs.Challenges of docking in large, flexible and promiscuous binding sites.Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics.Molecular mechanics (MM3(pi)) conformational analysis of molecules containing conjugated pi-electron fragments: Leucomycin-VBactericidal Disruption of Magnesium Metallostasis in Mycobacterium tuberculosis Is Counteracted by Mutations in the Metal Ion Transporter CorA
P50
Q35836815-27281199-C416-40C9-A9AF-C18C73222D33Q41996825-2FC694E4-B8AA-4F29-99A6-6C459B76746DQ47094774-11B562C2-E1A7-4A9C-92FF-C03EABDB0B2FQ48313123-EA80BFBF-9526-4415-9111-2D0A98AEA82FQ51559618-36082B75-F8B1-4669-AA19-A5A5735DF049Q53170357-DCB53704-F682-4373-AA11-5A7C5A48845EQ80854881-25FD36C6-4352-4179-B402-955C02EB32C9Q91753507-B6F8CAF6-F36B-4E27-851A-96EFE067FCE3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martin Kotev
@ast
Martin Kotev
@en
Martin Kotev
@es
Martin Kotev
@nl
Martin Kotev
@sl
type
label
Martin Kotev
@ast
Martin Kotev
@en
Martin Kotev
@es
Martin Kotev
@nl
Martin Kotev
@sl
prefLabel
Martin Kotev
@ast
Martin Kotev
@en
Martin Kotev
@es
Martin Kotev
@nl
Martin Kotev
@sl
P108
P106
P1153
8959994000
P31
P496
0000-0001-6178-6404